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Background: Rutin, a polyphenolic flavonoid, was investigated for its protective effects against the KBrO3 induced
renal injuries in rat.
Methods: Group I was control (untreated), group II was given saline 0.5 ml/kg bw (0.9% NaCl), group III was
administered KBrO3 (20 mg/kg bw) intragastric twice a week for four weeks. Rutin was administered to group VI (50
mg/kg bw) and Group V (70 mg/kg bw) along with KBrO3 (20 mg/kg bw) while group VI was given rutin (70 mg/
kg bw) alone twice a week for four weeks. Protective effects of rutin on KBrO3-induced nephrotoxicity in rats were
determined for biochemical parameter of urine, and serum, various antioxidant enzymes, DNA and
histopathological damages in kidneys.
Results: The level of urinary red blood cells, leucocytes count, specific gravity, urea, creatinine and urobilinogen
was increased (P<0.01) whereas creatinine clearance was reduced. Serum level of protein, albumin, globulin, nitrite,
creatinine and blood urea nitrogen (BUN) was significantly increased (P<0.01) by KBrO3. Marked histopathological
lesions, elevated DNA fragmentation and AgNORs count in renal tissues was determined. Activity of antioxidant
enzymes; catalase, superoxide dismutase, glutathione peroxidase, glutathione-S-transferase, glutathione reductase,
and reduced glutathione contents were decreased (P<0.01) while thiobarbituric acid reactive substances were
increased (P<0.01) with KBrO3 treatment in kidneys. DNA ladder assay was intimately related with the DNA
fragmentation assay. Telomerase activity was found positive in the KBrO3 treated kidneys. Treatment with rutin
effectively ameliorated the alterations in the studied parameters of rat. Rutin administration alone to rats did not
exhibit any significant change in any of the parameters studied.
Conclusion: These results suggest that rutin works as an antioxidant in vivo by scavenging reactive oxygen species
and this serves to prevent oxidative renal damage in rat treated with KBrO3.
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TelomeraseBackground
Potassium bromate (KBrO3) has been used widely for
water disinfection, hair-coloring solutions, cosmetics, and
in food [1]. Toxicological studies have suggested that
KBrO3 is: an oxidizing agent; causes hepatotoxicity,
neurotoxicity, and thyroid toxicity; and induces the devel-
opment of mesothelioma tumors in experimental animals
as well as renal carcinomas in animals and humans [2,3].
Several studies have investigated the oxidative injuries and
probable mechanism of KBrO3-induced carcinogenicity in* Correspondence: rahmatgul_81@yahoo.com
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reproduction in any medium, provided the orexperimental models [4-6]. KBrO3 induces mutations,
base modification (8-oxodeoxyguanosine), chromosomal
aberrations, and alters gene expression, leading to cancer
[7-9]. KBrO3 increases lipid peroxidation, the creatinine
concentration, and enzyme activity in the sera of rats.
Cellular defense against oxidative stress is provided by
several mechanisms. Antioxidant enzymes as well as non-
enzymatic compounds such as reduced glutathione
(GSH), ascorbic acid, and α-tocopherol all help to cope
with the potential damage caused by oxidative stress [10].
Free radicals produced by KBrO3 are associated with the
activation of telomerase activity. This activation induces
neoplasia, hyperplasia and tumor formation [11,12],d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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organizer regions (AgNORs) and can be utilized as an
indicator of genotoxicity to complement other histological
procedures [13,14].
Rutin (Figure 1) works as a scavenger of reactive oxi-
dative species (ROS) by donating hydrogen atoms to
peroxy radicals, superoxide anions, and singlet oxygen
and hydroxyl radicals; it also functions as a terminator
and chelator of metal ions that are capable of oxidizing
lipid peroxidation [15-17]. Rutin has been shown to
function as an anti-cancer, anti-viral, anti-bacterial and
anti-inflammatory agent. It is also used to treat cardio-
vascular and neurodegenerative disorders because of its
appreciable free radical-scavenging and anti-oxidant cap-
acities [18-20]. Additionally, studies suggest that rutin
alters signal transduction, causes activation of transcrip-
tion factors and gene expression, and may also protect
DNA by interacting with carcinogens that have escaped
detoxification processes [21-23].
The present study was therefore aimed at investigating
the effect of rutin on KBrO3-induced nephrotoxicity in
male Sprague–Dawley rats by the determination of bio-
chemical parameters and by histological examination.Methods
Chemicals
Reduced glutathione (GSH), oxidized glutathione
(GSSG), glutathione reductase, gamma-glutamyl p-
nitroanilide, glycylglycine, bovine serum albumin
(BSA), 1,2-dithio-bis nitro benzoic acid (DTNB), 1-
chloro-2,4-dinitrobenzene (CDNB), reduced nicotina-
mide adenine dinucleotide phosphate (NADPH), CCl4,
flavine adenine dinucleotide (FAD), glucose-6-phosphate,
Tween-20, 2,6-dichlorophenolindophenol, thiobarbituric
acid (TBA), picric acid, sodium tungstate, sodium hydrox-
ide, trichloroacetic acid (TCA) and perchloric acid (PCA)
were purchased from Sigma Chemicals Co. St. Louis,
USA.Figure 1 The structure of rutin.Animals and treatment
Six-week-old male Sprague–Dawley rats weighing 180±10 g
were provided with food and water ad libitum and kept at
20–22°C on a 12-h light–dark cycle. All experimental proce-
dures involving animals were conducted in accordance with
the guidelines of National Institutes of Health (NIH
guidelines Islamabad, Pakistan). The study protocol was
approved by Ethical Committee of Quaid-i-Azam University,
Islamabad. The rats were acclimatized to laboratory con-
dition for 7 days before commencement of experiment.
The following experimental groups (n = 06 rats per
group) were studied.
Group I: (control); the animals were remained
untreated.
Group II: animals were treated with saline (0.5 ml/kg
bw; 0.9% NaCl) intragastric twice a week for
four weeks.
Group III: was treated with KBrO3 (20 mg/kg bw;
aqueous) intragastric twice a week for four
weeks.
Group IV: was treated with KBrO3 (20 mg/kg bw;
aqueous) intragastric and rutin (50 mg/kg bw)
intragastric twice a week for four weeks.
Group V: rats were treated with KBrO3 (20 mg/kg bw;
aqueous) intragastric and rutin (70 mg/kg bw)
intragastric twice a week for four weeks.
Group VI: was treated with rutin (70 mg/kg bw)
intragastric twice a week for four weeks.
In addition all the rats were provided free access of
drinking water and food. After the completion of
dosages rats were kept individually in metabolic cages
for 24 h; collect the urine and volume was determined.
All the animals were sacrificed; blood was drawn prior
to the excision of organ. The serum was stored at −80°C
after separation until it was assayed as described below.
Half of kidney tissues were treated with liquid nitrogen
and stored at −80°C for further enzymatic analysis while
the other portion was processed for histology.
Analysis of urine
Urine samples were assayed for pH, specific gravity,
urea, creatinine, protein, albumin, urobilinogen, red
blood cells (RBCs) and white blood cells (WBCs) count
by using standard diagnostic kits (MediScreen Urine
Strips, Orgenics, France) and standard AMP diagnostic
kits (Stattogger Strasse 31b 8045 Graz, Austria) . Urinary
creatinine clearance was estimated by using the formula:
CrCl ¼ UxV=PXT
Where U: concentration of creatinine in urine
P: concentration of creatinine in plasma
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T: Time in minutes
Analysis of serum
Analysis of serum for blood urea nitrogen (BUN), nitrite,
creatinine, total protein, globulin, and albumin was esti-
mated by using standard AMP diagnostic kits (Stattogger
Strasse 31b 8045 Graz, Austria).
Assessment of antioxidant profile
Renal tissue was homogenized in 10 volume of 100
mmol KH2PO4 buffer containing 1 mmol EDTA (pH
7.4) and centrifuged at 12,000 × g for 30 min at 4°C.
The supernatant was collected and used for enzymatic
studies. Protein concentration of kidney tissue super-
natant was determined by the method of Lowry et al.
[24] using crystalline BSA as standard.
Catalase assay (CAT)
CAT activities were determined by the method of
Chance and Maehly [25] with some modifications. The
reaction solution of CAT activities contained: 2.5 ml of
50 mmol phosphate buffer (pH 5.0), 0.4 ml of 5.9 mmol
H2O2 and 0.1 ml enzyme extract. Changes in absorbance
of the reaction solution at 240 nm were determined after
one min. One unit of CAT activity was defined as an
absorbance change of 0.01 as units/min.
Superoxide dismutase assay (SOD)
SOD activity of lung tissues was estimated by the
method of Kakkar et al. [26]. Reaction mixture of this
method contained: 0.1 ml of phenazine methosulphate
(186 μmol), 1.2 ml of sodium pyrophosphate buffer
(0.052 mmol; pH 7.0), 0.3 ml of supernatant after centri-
fugation (1500 × g for 10 min followed by 10000 × g for
15 min) of lung homogenate was added to the reaction
mixture. Enzyme reaction was initiated by adding 0.2 ml
of NADH (780 μmol) and stopped after 1 min by adding
1 ml of glacial acetic acid. Amount of chromogen
formed was measured by recording color intensity at
560 nm. Results are expressed in units/mg protein.
Estimation of lipid peroxidation assay (TBARS)
The assay for lipid peroxidation was carried out with
modified method of Iqbal et al. [27]. The reaction mix-
ture in a total volume of 1.0 ml contained: 0.58 ml phos-
phate buffer (0.1 mol; pH 7.4), 0.2 ml homogenate
sample, 0.2 ml ascorbic acid (100 mmol), and 0.02 ml
ferric chloride (100 mmol). The reaction mixture was
incubated at 37°C in a shaking water bath for 1 h. The
reaction was stopped by addition of 1.0 ml 10%
trichloroacetic acid. Following addition of 1.0 ml 0.67%
thiobarbituric acid, all the tubes were placed in boiling
water bath for 20 min and then shifted to crushed ice-bath before centrifuging at 2500 × g for 10 min. The
amount of malonaldehyde formed in each of the samples
was assessed by measuring optical density of the super-
natant at 535 nm using spectrophotometer against a re-
agent blank. Tetramethoxypropane was used as an
external standard. The results were expressed as nmol of
TBARS/min/mg tissue protein.
Glutathione-S-transferase assay (GST)
The reaction mixture of glutathione-S-transferase activity
consisted of 1.475 ml phosphate buffer (0.1 mol, pH 6.5),
0.2 ml reduced glutathione (1 mmol), 0.025 ml (CDNB; 1
mmol) and 0.3 ml of tissue homogenate in a total volume
of 2.0 ml. The changes in the absorbance were recorded
at 340 nm and enzymes activity was calculated as nmol
CDNB conjugate formed/min/mg protein using a molar
extinction coefficient of 9.6 × 103M-1cm-1 [28].
Glutathione reductase assay (GSR)
Glutathione reductase activity was determined with the
protocol of Carlberg and Mannervik [29]. The reaction
mixture consisted of 1.65 ml phosphate buffer: (0.1 mol;
pH 7.6), 0.1 ml EDTA (0.5 mmol), 0.05 ml oxidized
glutathione (1 mmol), 0.1 ml NADPH (0.1 mmol) and
0.1 ml of homogenate in a total volume of 2 ml. Enzyme
activity was quantitated at 25°C by measuring disappear-
ance of NADPH at 340 nm and was calculated as nmol
NADPH oxidized/min/mg protein using molar extinc-
tion coefficient of 6.22 × 103 M-1cm-1.
Glutathione peroxidase assay (GSH-px)
Glutathione peroxidase activity was assayed by the
method of Mohandas et al. [30]. The reaction mixture
consisted of 1.49 ml phosphate buffer (0.1 mol; pH 7.4),
0.1 ml EDTA (1 mmol), 0.1 ml sodium azide (1 mmol),
0.05 ml glutathione reductase (1 IU/ml), 0.05 ml GSH (1
mmol), 0.1 ml NADPH (0.2 mmol), 0.01 ml H2O2 (0.25
mmol) and 0.1 ml of homogenate in a total volume of 2
ml. The disappearance of NADPH at 340 nm was
recorded at 25°C. Enzyme activity was calculated as
nmol NADPH oxidized/min/mg protein using molar ex-
tinction coefficient of 6.22 × 103 M-1cm-1.
Reduced glutathione assay (GSH)
1.0 ml sample of homogenate was precipitated with 1.0
ml of (4%) sulfosalicylic acid. The samples were kept at
4°C for 1 h and then centrifuged at 1200 × g for 20 min
at 4°C. The total volume of 3.0 ml assay mixture con-
tained: 0.1 ml filtered aliquot, 2.7 ml phosphate buffer
(0.1 mol; pH 7.4) and 0.2 ml DTNB (100 mmol). The
yellow color developed was read immediately at 412 nm
on a SmartSpecTM plus Spectrophotometer. It was
expressed as μmol GSH/g tissue [31].
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DNA fragmentation assay was conducted using the pro-
cedure of Wu et al. [32] with some modifications. The
tissue (50 mg) was homogenized in 10 volumes of a TE
solution pH 8.0 (5 mmol Tris–HCl, 20 mmol EDTA)
and 0.2% triton X-100. 1.0 ml aliquot of each sample
was centrifuged at 27,000 × g for 20 min to separate the
intact chromatin (pellet, B) from the fragmented DNA
(supernatant, T). The pellet and supernatant fractions
were assayed for DNA content using a freshly prepared
DPA (Diphenylamine) solution for reaction. Optical
density was read at 620 nm with (SmartSpecTM Plus
Spectrophotometer catalog # 170–2525) spectrophotom-
eter. The results were expressed as amount of % frag-
mented DNA by the following formula;
% Fragmented DNA ¼ Tx100= T þ Bð Þ
AgNORs count
Silver staining technique was used according to the
Trere et al. [33]. The AgNORs technique was performed
on dried slides as follows; unstained fixed slides were
dewaxed by dipping for 3 minutes in xylene. After
complete removal of wax the slides were hydrated in de-
crease ethanol concentration (90, 70 and 50%) and
washed in distilled water for 10 min and dried in an
oven. After drying slides were treated with one drop of
colloidal solution (2% gelatin and 1% formic acid) and
two drops of 50% AgNO3 solution onto the slide and
incubated at 35°C for about 8–12 min. The progressive
staining was followed under microscope to get golden
colored nuclei and brown/black NORs. Then, the slide
was washed in distilled water, treated for 1 min with 1%
sodium thiosulphate at room temperature to stop the re-
action, and washed in tap water. The cells were exam-
ined under light microscope at 100 × magnification and
number of AgNORs was counted per cell.
DNA ladder assay
DNA was isolated by using the methods of Gilbert et al.
[34]. To estimate DNA damages. 5 μg of rat DNA was
separately loaded in 1.5% agarose gel containing 1.0 μg/ml
ethidium bromide including DNA standards (0.5 μg per
well). Electrophoresis was performed for 45 min at 100
Volt. After electrophoresis gel was studied under gel doc
system and was photographed through digital camera.
RT-PCR (telomerase assay)
Telomerase activity was determined by the protocol of
Wen et al. [35] with some modifications.100 mg kidney
was washed in ice-cold wash buffer (10 mmol Hepes-
KOH pH 7.5, 1.5 mmol MgCl2, 10 mM KCl, 1 mM
dithiothreitol, 20 μl RNAs inhitors), and homogenised in200 μl ice cold lysis buffer. The homogenate was incu-
bated on ice for 30 min and then centrifuged at 10,000
×g for 30 min at 4°C. PCR reaction mixture (total 48 μl)
consisted of 36.6 μl DEPC treated water, 2 μl (6 μg
protein) extract, 5 μl 10x TRAP reaction solution, 2 μl
(50 μmol) each dNTP, 0.4 μl (2 U) Taq DNA polymerase,
and 2 μl (0.1 μg) of TS primer sequence (5'-
AATCCGTCGAGCAGAGTT-3'). The PCR reaction
mixture was incubated at 25°C in water bath for 30 min
for extension of TS primer. CX primer sequence (5'-
CCCTTACCCTTACCCTTACCCTAA-3') 2 μl (0.1 μg)
was added. The reaction mixture (total 50 μl) was sub-
jected to PCR cycles (25) at 94°C for 30s, 55°C for 30s,
and 72°C for 90s (then 10 min for the final step). After
amplification 5μl of loading dye (0.25% bromophenol
blue, 0.25% xylenocyanol and 50% glycerol) was mixed
to each PCR product and 25 μl of each sample were
loaded onto a 12.5% non-denaturing polyacrylamide gel.
After complete running of gel was fixed in fixing solu-
tion (0.5% acetic acid, 10% ethanol) and stained with
0.2% AgNO3 for 10 min, followed by 15 min incubation
in developing solution (0.1% formaldehyde and 3%
NaOH) and then photographed.
Histopathalogical determination
For microscopic evaluation tissues were fixed in a fixa-
tive (absolute ethanol 60%, formaldehyde 30%, and gla-
cial acetic acid 10%) and embedded in paraffin,
sectioned at 4 μm and subsequently stained with
hematoxylin/eosin. Sections were studied under light
microscope (DIALUX 20 EB) at 40 and 100 magnifica-
tions. Slides of all the treated groups were studied and
photographed. A minimum 12 fields of each section
were studied and approved by pathologist without saying
of its treatment nature.
Statistical analysis
The values were expressed as the mean ± SEM for the
06 rats in each group. Differences between groups were
assessed by one-way analysis of variance (ANOVA) using
the Statistical Package for Social Sciences (SPSS) soft-
ware package for Windows (version 13.0). Post hoc test-
ing was performed for intergroup comparisons using the
least significant difference (LSD) test. A value corre-
sponding to P<0.05 was deemed to be statistically
significant.
Results
Effects of rutin on urine profile
Reactive oxygen species (ROS) especially nephrotoxic
chemicals effects the urinary profile of kidney. Table 1
shows the changes in renal profile including pH, specific
gravity, RBCs and WBCs count, creatinine, creatinine
clearance, urea, urobilinogen, protein, and albumin level.
Table 1 Effects of rutin on physical and biochemical parameters of urine
Treatment pH Specific gravity Urea (mg/dl) Creatinine (mg/dl) Creatinine clearance
(ml/min)
Control 7.2±0.07++ 1.2±0.02++ 93.0±2.0++ 38.0±1.34++ 3.4±1.3++
Saline (0.5 ml/kg bw; 0.9% NaCl) 7.1±0.04++ 1.1±0.01++ 91.0±3.25++ 36.2±0.09++ 3.3±0.8++
KBrO3 (20 mg/kg bw) 6.3±0.08
** 1.8±0.05 ** 195.30±3.98++ 86.7±3.89** 1.1±1.9**
KBrO3+Rutin (50 mg/kg bw) 6.7±0.10
++ 1.2±0.07++ 110.0±2.01*++ 53.5±1.52++ 2.7±1.6*++
KBrO3+Rutin (70 mg/kg bw) 7.0±0.03
++ 1.2±0.04++ 103.1±3.5++ 46.3±2.31++ 3.1±1.3++
Rutin alone (70 mg/kg bw) 7.1±0.04++ 1.2±0.06++ 92.2±3.0++ 39.1±1.03++ 3.5±0.3++
Treatment RBC/μl WBC/μl Protein (mg/dl) Albumin (mg/dl) Urobilinogen
(mg/dl)
Control 0.02±0.00++ 16.0±1.81++ 42.8±2.3 ++ 18.2±2.76++ 2.47±0.22++
Saline (0.5 ml/kg bw; 0.9% NaCl) 0.03±0.05++ 19.6±1.15++ 43.0±3.2++ 19.0±3.9++ 2.43±0.21++
KBrO3 (20 mg/kg bw) 25.7±1.84
** 68.0±5.0** 100.0±1.2** 34.7±1.86** 15.7±1.89**
KBrO3+Rutin (50 mg/kg bw) 8.8±0.15
**++ 41.00±2.25**++ 55.0±1.2++ 24.7±1.86++ 5.67±1.89++
KBrO3+Rutin (70 mg/kg bw) 2.3±0.12
**++ 22.5±1.3++ 45.7±2.1++ 20.6±1.25++ 3.62±1.23++
Rutin alone (70 mg/kg bw) 2.0±0.95**++ 18.66±0.95++ 39.0±2.3++ 17.33±3.71++ 2.933±0.25++
Mean ± SEM (n=6 number).
*, ** indicate significance from the control group at P<0.05 and P<0.01 probability level.
++ indicate significance from the KBrO3 group at P<0.01 probability level.
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cantly (P<0.01) increased the level of specific gravity,
RBCs and WBCs count, creatinine, urea, urobilinogen,
protein, and albumin level whereas decreased (P<0.01)
the pH and creatinine clearance as compared to the con-
trol group. Treatment of rutin attenuated the KBrO3 in-
toxication, dose dependently, and decreased (P<0.01) the
specific gravity, RBCs and WBCs count, urea, creatinine,
urobilinogen, protein and albumin while increased the
pH and creatinine clearance of urine. Rats treated with
rutin (70 mg/kg bw) alone did not statistically (P>0.05)
change the parameters studied to that of the control
group.Effects of rutin on serum profile
Table 2 shows the assessment of serum biomarkers i.e.
concentration of nitrite, creatinine, BUN, total protein;
albumin and globulin indicate the functional integrity of
the kidneys. KBrO3 administration significantly (P<0.01)
increased the level of nitrite, creatinine while signifi-
cantly (P<0.01) decreased the total protein, albumin and
globulin as compared to control group. Serum level of
these parameters were significantly (P<0.01) improved
by administration of rutin as compared to KBrO3 treated
rats. However, more restoration effects on studied para-
meters were determined at the higher dose (70 mg/kg
bw) of rutin. These parameters were statistically
(P>0.05) remained unchanged with the treatment of
rutin (70 mg/kg bw) alone as compared to the control
group of rat.Effects of rutin on antioxidant profile
The results regarding the protective effects of rutin
against the toxic affect of KBrO3 in rat on kidney protein
and activities of antioxidant enzymes such as CAT, SOD,
GSH-Px, GSR and GST are shown in Table 3. Activities
of antioxidant enzymes such as CAT, SOD, GSH-Px,
GSR and GST were reduced (P<0.01) by treatment of
KBrO3 as compared to control group. This reduction in
enzymes activity was reversed significantly (P<0.01), in a
concentration dependent way, by the treatment of rutin
as compared to the KBrO3 group. Alteration in the renal
enzyme activities with the treatment of rutin (70 mg/kg
bw) alone was statistically (P>0.05) remained unchanged
as compared to the control group of rat.Effects of rutin on TBARS, GSH, DNA fragmentation and
AgNORs
Table 4 shows the changes of protection by rutin versus
the KBrO3 intoxication of rat on TBARS, GSH, DNA
fragmentation and AgNORs count in kidney of rat.
Treatment of KBrO3 significantly (P<0.01) increased the
contents of TBARS, DNA fragmentation and AgNORs
count while significantly (P<0.01) decreased the content
of GSH in kidneys as compared to control group. Con-
centration of TBARS, AgNORs count, and DNA injuries
was significantly decreased (P<0.01) by administration of
rutin, in a dose dependent way, in rat treated with
KBrO3. Level of renal GSH was significantly (P<0.01)
increased by administration of rutin as compared to the
KBrO3 treated group. However these effects were more
Table 2 Effects of rutin on serum profile
Treatment Nitrite (μmol/ml) Creatinine (mg/dl) BUN (mg/dl) Protein (mg/dl) Globulin (mg/dl) Albumin (mg/dl)
Control 25.7±1.4++ 36.55±0.84++ 41.0±2.04++ 42.83±2.26 ++ 24.67±1.33++ 18.17±2.76++
Saline (0.5 ml/kg bw; 0.9% NaCl) 24.9±1.7++ 34.9±0.24++ 43.0±2.56++ 43.6±2.0 ++ 23.07±1.83++ 17.10±2.25++
KBrO3 (20 mg/kg bw) 72.12±3.4
** 90.0±7.06** 125.9±3.5** 23.00±1.18** 12.33±1.54** 10.67±1.86**
KBrO3+Rutin (50 mg/kg bw) 32.0±2.6
++ 50.3±1.58++ 65.8±5.58++ 33.33±1.54**++ 16.17±1.14**++ 13.16±1.42*++
KBrO3+Rutin (70 mg/kg bw) 25.3±2.3
++ 43.6±2.15++ 52.6±4.62++ 37.65±2.16++ 20.42±1.64++ 16.53±1.26++
Rutin alone (70 mg/kg bw) 22.3±1.9++ 35.17±1.9++ 40.17±3.75++ 38.00±2.27++ 19.67±2.01++ 17.33±3.71++
Mean ±SEM (n=6 number).
** indicate significance from the control group at P<0.01 probability level.
++ indicate significance from the KBrO3 group at P<0.01 probability level.
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Statistically nonsignificant (P>0.05) alterations on
TBARS, GSH, DNA fragmentation and AgNORs count
in kidney of rat was determined with rutin (70 mg/kg
bw) alone as compared to the control group.Effects of rutin on percent increase in body weight,
absolute kidney weight and relative kidney weight
Protective effects of different dosages of rutin against
KBrO3 administration to rat on percent increase in body
weight, absolute kidney weight and relative kidney
weight are shown in Table 5. Administration of KBrO3
to rats significantly increased (P<0.01) the absolute kid-
ney weight, relative kidney weight while significantly
decreased (P<0.01) the percent increase in body weight
for four experimental weeks as compared to the control
group. Administration of rutin consistently restored
(P<0.01) the percent increase in body weight, kidney
weight and relative kidney weight as compared to the
KBrO3 group. More protective effects of rutin for the
percent increase in body weight, kidney weight and rela-
tive kidney weight against the KBrO3 intoxication to rats
were determined at the higher concentration of rutin (70
mg/kg bw). Administration of rutin alone did not cause
any significant (P>0.05) change in the percent increase
in body weight, absolute kidney weight and relative kid-
ney weight as compared to the control group.Table 3 Effects of rutin on renal antioxidant profile
Treatment CAT (U/min) SOD (U/mg prote
Control 18.2±2.2++ 19.05±1.54++
Saline (0.5 ml/kg bw; 0.9% NaCl) 18.5±2.6++ 19.75±1.4++
KBrO3 (20 mg/kg bw) 7.5±0.85
** 7.58±2.08**
KBrO3+Rutin (50 mg/kg bw) 11.5±2.2
*++ 12.83±1.87*++
KBrO3+Rutin (70 mg/kg bw) 16.5±2.6
++ 17.62±2.14++
Rutin alone (70 mg/kg bw) 17.37±1.17++ 20.72±1.72++
Mean ± SEM (n=6 number).
*, ** indicate significance from the control group at P<0.05 and P<0.01 probability
++ indicate significance from the KBrO3 group P<0.01 probability level.Effect of rutin on DNA damages (DNA ladder assay)
KBrO3 forming DNA-free radical adduct, induces DNA
damages in the kidneys of rats. DNA ladder assay of kid-
neys showed the severe DNA damages in the KBrO3
treated group of rat. However, administration of rutin to
KBrO3 treated animals reduced the DNA damages, dose
dependently, as shown by DNA banding patterns of dif-
ferent groups of rutin (50 and 70 mg/kg bw) as com-
pared to KBrO3 group (Figure 2).
RT-PCR (telomerase enzyme assay)
Telomerase enzyme assay was used to find out the tel-
omerase enzyme activity in various groups of this study
(Figure 3). Presence of a single band (primer) in lane
(1–2; control group) and in lane (3–6; KBrO3 + rutin
groups) showed that amplification was absent, and indi-
cated the protective effects of rutin while KBrO3 treated
group showed positive telomerase activity (lane 7–8)
having two or more DNA bands.
Effects of rutin on histological changes of kidneys
The histological changes were graded and summarized
in Table 6. The sections of control group showed normal
histology including normal glomerulus, bowman capsule,
distal and proximal convoluted tubules. Marked histo-
logical changes were observed in cortex of kidneys in
KBrO3-treated rats. The cross section showed tubular






45.33±1.65++ 203.3±10.3 ++ 123.8±13.3++
43.5±1.35++ 200.6±8.3 ++ 121.8±10.3++
23.35±3.08 ** 114.5±20.7** 53.8±26.1**




Table 4 Effects of rutin on renal level of TBARS, GSH, AgNORs and DNA fragmentation
Treatment TBARS (nmol/min/mg protein) GSH (μmol/g tissue) DNA fragmentation% AgNORs (NORs/cell)
Control 8.17±0.93++ 1.72±0.157++ 7.75±0.834++ 1.86±0.10++
Saline (0.5 ml/kg bw; 0.9% NaCl) 8.2±0.73++ 1.68±0.17++ 7.65±0.94++ 1.81±0.12++
KBrO3 (20 mg/kg bw) 20.90±1.91
** 0.73±0.15** 54.42±1.02** 8.08±0.52**
KBrO3+Rutin (50 mg/kg bw) 15.17±1.20
++ 1.28±0.19*++ 27.85±1.26++ 2.23±0.09++
KBrO3+Rutin (70 mg/kg bw) 10.25±1.35
++ 1.58±0.16++ 9.25±1.35++ 2.12±0.06++
Rutin alone (70 mg/kg bw) 9.17±1.06++ 1.760±0.0817++ 8.08±1.17++ 1.95±0.13++
Mean ±SE M (n=6 number).
** indicate significance from the control group at P<0.01 probability level.
++ indicate significance from the KBrO3 group at P<0.01 probability level.
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Treatment of rutin to KBrO3 treated rats markedly
recovered the toxic changes near to the control rat. Hist-
ology of the kidneys showed normal glomerulus, bow-
man capsule, reversed the tubular degeneration,
congestion and dilatation and prevented interstitial
edema and capillary congestion in a dose dependent
way. However, treatment of rutin (70 mg/kg bw) alone
did not induce histopathological changes in kidneys.Discussion
Rutin modulates several biological functions and
exhibits anti-cancer, anti-viral, anti-bacterial and anti-
inflammatory activities due to its appreciable free
radical-scavenging and anti-oxidant capacities [18-20].
At the end of the study period, KBrO3 treatment was
found to have decreased the percent increase in body
weight but increased the absolute kidney weight and
relative kidney weight as compared with the control
group. Similar alterations for these parameters with
KBrO3 have been determined previously [36-38]. In the
present study, the observations made with respect to
percent increase in body weight, absolute kidney weight
and relative kidney weight in male Sprague–Dawley rats
appeared to suggest that rutin can alleviate KBrO3-
induced toxicity in these animals.Table 5 Effects of rutin on body weight, kidney weight and re
Treatment Percent increase in body weight (g
Ist week 2nd week
Control 6.3±0.6++ 13.4±1.3++
Saline (0.5 ml/kg bw; 0.9% NaCl) 6.6±0.5++ 13.8±2.1++
KBrO3 (20 mg/kg bw) 3.4±0.3
** 7.6±1.5**
KBrO3+Rutin (50 mg/kg bw) 4.4±0.3
*++ 10.4±1.2*++
KBrO3+Rutin (70 mg/kg bw) 4.9±0.4
++ 12.6±1.4++
Rutin alone (70 mg/kg bw) 6.2±0.4++ 14.8±1.3++
Mean ±SEM (n=6 number).
*, ** indicate significance from the control group at P<0.05 and P<0.01 probability
++ indicate significance from the KBrO3 group at P<0.01 probability level.Urinalysis provides important clues about acid–base
balance and kidney function [39]. Urobilinogen is a con-
jugated product of bilirubin, which passes through the
bile duct and is metabolized in the intestine [40,41].
High levels of urobilinogen, urea, creatinine, protein and
albumin in urine reflect the kidney dysfunction and
renal injuries induced by KBrO3 treatment [42,43].
Increased specific gravity is a basic symptom of dehydra-
tion, renal artery steatosis, necrosis, and decreased blood
flow to the kidneys. In addition, increased RBC and
WBC counts in the urine of KBrO3-treated rats sug-
gested severe injuries to renal tissues. Higher levels of
protein and the number of RBCs and WBCs might have
also contributed to the values of specific gravity obtained
in the present study. This increase in specific gravity
consequently reflects the high degree of damage to kid-
ney tissue. The hematuria and proteinuria observed in
the present study could be related to necrosis and kid-
ney dysfunction [44]. Ogawa et al. [45] also found that
the glomerular capillary wall is permeable to low-
molecular-weight (LMW) proteins. Therefore, an appre-
ciably high level of proteinuria indicates the leakage of
LMW proteins. The oxidative stress induced by KBrO3
might promote the formation of various vasoactive med-
iators that can affect renal function directly by initiating
renal vasoconstriction or decreasing the glomerular ca-







3rd week 4rth week
21.3±2.3++ 28.2±3.4++ 4.0±0.08++ 0.040±0.00072++
22.4±2.6++ 27.6±3.2++ 4.0±0.08++ 0.040±0.00072++
10.2±1.6** 14.4±2.6** 4.9±0.60** 0.049±0.00125**
15.3±1.4*++ 19.6±2.4++ 4.50±0.12++ 0.045±0.00079++
19.6±1.5++ 23.4±3.2++ 4.23±0.14++ 0.042±0.0014++
22.7±1.6++ 27.8±2.4++ 4.12±0.06++ 0.041±0.00049++
level, respectively.
Figure 2 Agarose gel showing KBrO3-induced DNA damages in kidneys and preventive effects of rutin in various experimental groups
of rat. Lanes (from left) DNA marker (M), Control (1–2), Saline (0.9% NaCl) 0.5 ml/kg bw (3–4), KBrO3 20 mg/kg bw (5–8), KBrO3 (20 mg/kg bw) +
rutin 50 mg/kg bw (9–11), KBrO3 (20 mg/kg bw) + rutin 70 mg/kg bw (12–13), rutin alone 70 mg/kg bw (14–16).
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Rutin administration to rats treated with KBrO3 amelio-
rated the toxicity of KBrO3 in kidneys to restore the
level of the studied parameters in a concentration-
dependent manner. These results suggest that rutin can
be used as renoprotective agent against KBrO3 induced
toxicity.
The present study revealed that KBrO3 administration
caused marked increases in the serum levels of creatin-
ine, urobilinogen, BUN, total bilirubin and direct biliru-
bin, as reported previously [23,46]. In addition, elevated
levels of urinary albumin and reduced levels of serum al-
bumin in KBrO3-treated rats might have resulted from
considerable leakage due to injuries to glomeruli and
tubules. The results suggested that rutin prevented
KBrO3-induced toxicity, and that the levels of creatinine,
urobilinogen, BUN, total bilirubin, and direct bilirubin
could be altered to those seen in the control group.
Other studies have shown that different plant extracts
can significantly reduce the renal injuries induced
through KBrO3 intoxication [12,23,43]. There is a large
body of evidence implicating oxidative stress and ROS in
the mechanism of KBrO3-induced toxicity in animalFigure 3 Polyacrylamide gel shows the telomerase enzyme
activity in various groups of the study. Lane (1–2) control group,
Lane (3–4) KBrO3 (20 mg/kg bw) + rutin (50 mg/kg bw) group, Lane
(5–6) KBrO3 (20 mg/kg bw) + rutin (70 mg/kg bw), Lane (7–8) KBrO3
(20 mg/kg bw) group.models [10]. In the present study, the mean activity of
the antioxidant enzymes CAT, SOD, GSH-Px, GST and
GSR were found to be significantly lowered in the
KBrO3-treated group compared with that of the control
group. Lowered activities of these antioxidant enzymes
with KBrO3 in in-vivo experimental models have been
reported [47]. However, the treatment of rutin with
KbrO3 modified the biochemical changes caused by
KBrO3 in rat. In the present study, the mean activities of
antioxidant enzymes were significantly higher compared
with those of the KBrO3-treated group and thus had a
potential protective effect.
GSH is a vital extracellular and intracellular protective
antioxidant against oxidative stress. It reduces hydrogen
peroxides and hydroperoxides by its redox and detoxifi-
cation reactions, and protects protein thiol groups from
oxidation. This tripeptide is present in high concentra-
tions in kidney cells. In the present study, the mean level
of GSH upon KBrO3 treatment was depleted in the kid-
neys compared with that seen in the control group. Fol-
lowing decreases in the level of GSH, oxidative stress
increases and, thereafter, cell damage occurs [47]. In the
present study, the animals receiving KBrO3 showed
glomerular injuries, tubular necrosis, tubular dilatation,
tubular cell swelling and tubular brush border loss. En-
dogenous levels of GSH were found to be increased with
an accompanying increase in the mean activities of
GSH-Px, GST and GSR with rutin to that of the KBrO3-
treated group. By the catalyses of GSH-Px, GSH is oxi-
dized to GSSG, which can then be reduced back to GSH
by GSR. GSH is also a cofactor for the phase-II enzyme
GST, which confers protection against toxic chemicals
by catalyzing the formation of GSH-electrophile conju-
gates [48].
Free radicals and reactive oxygen species mediate the
propagation of peroxidation of polyunsaturated fatty
acids, this cascade can be prevented through enzymatic
and non-enzymatic antioxidants. Increased TBARS
Table 6 Effects of rutin on renal histopathology of rat
Treatment Tubular dilatation Tubular necrosis Tubular cell swelling Tubular congestion Glomerular injuries
Control - - - - -
Saline (0.5 ml/kg bw; 0.9% NaCl) - - - - -
KBrO3 (20 mg/kg bw) ++ ++ ++ −/+ −/+
KBrO3+Rutin (50 mg/kg bw) −/+ −/+ −/+ - -
KBrO3+Rutin (70 mg/kg bw) - - - - -
Rutin alone (70 mg/kg bw) - - - - -
-, normal; −/+, mild; ++, medium damaged.
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be result of increased oxidative stress. TBARS, the final
metabolite of peroxidized polyunsatured fatty acids [49],
considered as a late biomarker of oxidative stress [50-52],
not only translate reactive oxygen species into active
chemicals but also magnifies the function of reactive
oxygen species through the chain reaction, inducing
alterations in cellular and functional impairment [53],
and serves to indicate the presence of free radicals,Figure 4 H & E stain. Representative section of kidney, Control group; no
bw) group; injuries in glomeulus and bowman capsule (B), KBrO3 (20 mg/k
(C), KBrO3 (20 mg/kg bw) group; tubular congestion (D), KBrO3 (20 mg/kg
mg/kg bw) group (F).lipid peroxide formation [54,55]. The increment in
lipid peroxidation as assessed by the elevated levels of
TBARS following KBrO3 administration has been well
documented in other studies [39,56]. This may be the
consequence of an increment in the formation of oxy-
gen free radicals (generated by KBrO3) since antioxi-
dant defense systems are compromised [10]. Lower
concentration of TBARS with rutin in KBrO3 treated ani-
mals obtained in this study indicates the amelioratingrmal tubules, glomerulus and bowman capsule (A), KBrO3 (20 mg/kg
g bw) group, tubular necrosis, tubular cell swelling, tubular dilatation
bw) + rutin (50 mg/kg bw) group (E), KBrO3 (20 mg/kg bw) + rutin (70
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KBrO3 in kidneys.
Oxidative damage to DNA is a result of interaction of
DNA with reactive oxygen species (ROS), in particular
the hydroxyl radical, produces a multiplicity of modifica-
tions in DNA; generating strand breaks with various
sugar modifications, and release of free bases from nu-
cleic acid. The present study showed increased percent-
age of DNA fragmentation in the KBrO3 treated rat
kidneys. This reveals that KBrO3 induces oxidative stress
to the cells thus causing damage to DNA. Increase in
oxidative status with KBrO3 in kidneys can permit fur-
ther oxidation of cellular DNA resulting in the forma-
tion of the mutagenic lesion, 8-oxodeoxyguanosine
[6,49]. GSH and other sulfhydryls play a major role in
the excretion of bromate in the rat kidney [3]. Thiol-
mediated oxidation of DNA by bromine oxides and
bromine radicals has been well characterized in vitro
and are thought to play a role in DNA damage in vivo
[5], while extra cellular pools of GSH may be important
in protecting target organs from bromate uptake and
oxidative DNA damage [39], intracellular GSH may fa-
cilitate the formation of DNA reactive metabolites [57].
Telomeres are specialized structures present at the
ends of chromosomes possessing highly conserved G
rich sequence TTAGGG in all eukaryotic cells that are
gradually decreases during cell division of cell cycle. Tel-
omerase is a key enzyme for synthesis of telomeric
repeats and is used as a diagnostic tool for malignant
tumors [58,59] and in cell lines [60]. Activity of telomer-
ase was found positive in KBrO3 treated kidneys indicat-
ing the involvement of oxidative stress in the activation
of telomerase. However, telomerase activity was not
determined in control as well as in rutin treated groups,
which might be due to the presence of various telomer-
ase and cancer inhibitor compounds [61,62]. Similar
results have been documented in different studies
[63,64]. Renal dysfunction induced by KBrO3 in experi-
mental animals characterized by tubular damage, loss of
brush border, tubular necrosis, tubular dilatation, tubular
cell swelling and glomerular injuries [44,65]. It is
believed that these histopathological changes can alter
the capacity of tubular absorption, thus bringing about
functional overload of nephrons with subsequent renal
dysfunction [12,23], which was normalized by co-
treatment with rutin. Similar observations were also
observed by co-treatment with caffeic acid phenyl ester
[43].
Conclusion
The protective role of rutin at different levels was evalu-
ated in this manuscript. It may contribute its protective
effects by erasing the damaging action of potassium bro-
mate at various metabolic cycles, and the repair of DNAdamage. The protective potential may involve scavenging
potential and antioxidant capacity to ameliorate the
KBrO3 induced toxicity. This study substantiated the sci-
entific evidence in favors of its pharmacological use in
renal injuries.
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